— Know what they know.
Not Investment Advice

SNNAQ OTC

Sienna Biopharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +9900.0% 1Y: +9900.0% 3Y: -0.0% 5Y: -99.4%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $3091 mcap · 31M float · 0.0033% daily turnover

Balance Sheet Trends

Total Assets
$107M -21.6% ▼
3Y CAGR: +165.2%
Total Liabilities
$81M +76.8% ▲
3Y CAGR: +261.9%
Shareholders Equity
$159M +85.5% ▲
3Y CAGR: +240.1%
Cash & Investments
$49M -34.8% ▼
3Y CAGR: +113.8%
Total Debt
$30M +0.0% ▲
Net Debt
-$18M +75.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2015FY2016FY2017FY2018
— Assets —
Cash$5M$9M$74M$49M
Short-Term Investments$0$0$0$0
Cash & ST Investments$5M$9M$74M$49M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$24K$94K$2M$181K
Total Current Assets$6M$11M$77M$50M
Property, Plant & Equip.$114K$291K$432K$311K
Goodwill & Intangibles$0$52M$59M$57M
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0$2K$0$0
Total Non-Current Assets$114K$52M$60M$57M
Total Assets$6M$62M$137M$107M
— Liabilities —
Accounts Payable$806K$2M$2M$3M
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$0
Other Current Liabilities$0$7M$3M$18M
Total Current Liabilities$1M$10M$8M$24M
Long-Term Debt$0$0$0$30M
Other Non-Current Liab.$694K$21M$26M$16M
Total Non-Current Liabilities$694K$30M$37M$56M
Total Liabilities$2M$40M$46M$81M
— Equity —
Common Stock$1K$1K$2K$0
Retained Earnings-$14M-$35M$86M$159M
Accumulated OCI$0-$366K$5M$3M
Total Stockholders Equity$4M$22M$86M$159M
Total Liabilities & Equity$6M$62M$132M$240M
— Key Metrics —
Total Debt$0$0$0$30M
Net Debt-$5M-$9M-$74M-$18M
Total Investments$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms